Should epitope-based HLA compatibility be used in the kidney allocation system?

Area of Science:

• Immunogenetics
• Transplantation immunology
• Nephrology

Background:

• Current kidney allocation systems (KAS) primarily use HLA antigen-level matching.
• Sensitized transplant candidates with HLA antibodies have specific reactivities tied to epitopes, not just antigens.
• Existing systems struggle to accurately assess unacceptable mismatches for these patients.

Purpose of the Study:

• To describe an epitope-based human leukocyte antigen (HLA) compatibility system for kidney allocation.
• To enhance the accuracy of mismatch assessment for sensitized kidney transplant candidates.
• To integrate epitope specificity into the KAS for improved donor-recipient matching.

Main Methods:

• Utilizing recipient and donor HLA typing at the four-digit allele level.
• Performing HLA class I and class II epitope specificity analyses using serum antibody assays.
• Developing software to identify compatible HLA types based on epitope mismatches.
• Entering epitope-specific unacceptable mismatches into the transplant candidate database.

Main Results:

• Demonstrated the feasibility of an epitope-based HLA compatibility system.
• Showcased the ability to perform detailed epitope specificity analyses.
• Highlighted the potential for newly developed software to identify compatible HLA types efficiently.
• Provided a framework for incorporating epitope data into KAS.

Conclusions:

• An epitope-based HLA compatibility system offers a more scientifically accurate approach to kidney allocation.
• This system is particularly beneficial for sensitized patients with HLA antibodies.
• Implementing epitope-level matching can improve the identification of compatible kidney transplants.
• Further integration of epitope data into KAS is recommended for optimized outcomes.